Loading...
XNYS
INSP
Market cap1.48bUSD
Jul 09, Last price  
51.52USD
1D
4.50%
1Q
-4.63%
IPO
110.54%
Name

Inspire Medical Systems Inc

Chart & Performance

D1W1MN
XNYS:INSP chart
P/E
10.21
P/S
1.63
EPS
5.05
Div Yield, %
Shrs. gr., 5y
2.68%
Rev. gr., 5y
51.21%
Revenues
912m
+13.60%
8,012,00016,427,00028,567,00050,593,00082,050,000115,381,000233,394,000407,856,000624,799,000802,804,000911,981,000
Net income
145m
+171.77%
-21,337,000-18,528,000-17,511,000-21,828,000-33,243,000-57,203,000-42,042,000-44,881,000-21,153,00053,509,000145,422,000
CFO
117m
-10.19%
-22,254,000-17,949,000-15,791,000-18,694,000-33,377,000-53,045,000-20,119,00011,569,00024,653,000130,246,000116,976,000
Dividend
Jan 09, 20089 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
IPO date
May 03, 2018
Employees
755
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT